Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-037862
Filing Date
2010-02-24
Accepted
2010-02-23 19:31:27
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1548429
2 LIST OF SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 2977
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 9247
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 9271
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 dex321.htm EX-32.1 4104
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 dex322.htm EX-32.2 4134
7 GRAPHIC g42866tx_pg033.jpg GRAPHIC 19234
  Complete submission text file 0001193125-10-037862.txt   1606367
Mailing Address 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808
Business Address 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808 49 6172 608 2327
Fresenius Kabi Pharmaceuticals Holding, Inc. (Filer) CIK: 0001439449 (see all company filings)

EIN.: 980589183 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34172 | Film No.: 10627936
SIC: 2834 Pharmaceutical Preparations